Your session is about to expire
← Back to Search
Essential Oil
Peppermint Oil for Bladder and Bowel Dysfunction in Children
N/A
Waitlist Available
Led By Heidi A. Stephany, MD
Research Sponsored by Children's Hospital of Orange County
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether peppermint oil can help children with bladder and bowel problems. Children will take peppermint oil capsules regularly for a few months. Researchers will check if their symptoms improve. Peppermint oil has been studied for its effects on irritable bowel syndrome and other gastrointestinal issues.
Who is the study for?
This trial is for children aged 8-17 who weigh at least 30kg and have bladder and bowel dysfunction not caused by nerve issues. They should have tried behavioral therapy without success and be able to swallow pills. It's not for kids with certain neurological conditions, severe urinary tract problems, learning disabilities, recent oxybutynin use, or gastrointestinal disorders.
What is being tested?
The study tests if peppermint oil capsules taken three times daily can improve symptoms of bladder and bowel dysfunction in children. The effectiveness will be measured using a questionnaire before starting treatment and after eight weeks of taking the oil.
What are the potential side effects?
While the trial information doesn't specify side effects, generally peppermint oil can cause heartburn, allergic reactions, flushing, headache and mouth sores when consumed in large doses.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Symptom score
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Peppermint OilExperimental Treatment1 Intervention
Peppermint oil will be provided free of charge to participants under the trademark Pepogest produced by the maker Nature's Way® (dosage 0.2 mL, 181 mg peppermint oil).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peppermint Oil
2016
N/A
~50
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for bladder and bowel incontinence often target the relaxation of smooth muscles and reduction of spasms in the gastrointestinal and urinary tracts. For example, peppermint oil is being studied for its potential to relax smooth muscles and reduce spasms, which can alleviate symptoms of incontinence.
This is crucial for patients as it can improve their quality of life by reducing the frequency and urgency of incontinence episodes. Other treatments, such as intravesical capsaicin, work by reducing suburothelial nerve densities, thereby decreasing detrusor hyperreflexia and improving bladder control.
These mechanisms are important as they directly address the underlying causes of incontinence, providing more effective symptom management.
Effect of the extracts of pumpkin seeds on the urodynamics of rabbits: an experimental study.Intravesical capsaicin for treatment of detrusor hyperreflexia.Early capsaicin intervention for neurogenic bladder in a rat model of spinal cord injury.
Effect of the extracts of pumpkin seeds on the urodynamics of rabbits: an experimental study.Intravesical capsaicin for treatment of detrusor hyperreflexia.Early capsaicin intervention for neurogenic bladder in a rat model of spinal cord injury.
Find a Location
Who is running the clinical trial?
Children's Hospital of Orange CountyLead Sponsor
34 Previous Clinical Trials
5,247 Total Patients Enrolled
Heidi A. Stephany, MDPrincipal InvestigatorChildren's Hospital, Orange County
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can swallow pills.I weigh less than 30 kg.I have taken oxybutynin in the last 30 days.I have a hiatal hernia, severe GERD, or gallbladder issues, or I'm on medication for these.I am a child aged 8-17, weigh at least 30kg, and my bladder and bowel issues haven't improved with behavior therapy.I have bladder issues, learning disabilities, or have had surgery for bladder/bowel problems.
Research Study Groups:
This trial has the following groups:- Group 1: Peppermint Oil
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger